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Abstract
The EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS) provides a scientiﬁc
opinion re-evaluating the safety of sodium, potassium and calcium salts of fatty acids (E 470a) and
magnesium salts of fatty acids (E 470b) when used as food additives. In 1991, the Scientiﬁc
Committee on Food (SCF) established a group acceptable daily intake (ADI) ‘not speciﬁed’ for the fatty
acids (myristic-, stearic-, palmitic- and oleic acid) and their salts. The sodium, potassium, calcium and
magnesium salts of fatty acids are expected to dissociate in the gastrointestinal tract to fatty acid
carboxylates and their corresponding cations. There were no data on subchronic toxicity, chronic
toxicity, reproductive and developmental toxicity of the salts of fatty acids. There was no concern for
mutagenicity of calcium caprylate, potassium oleate and magnesium stearate. From a carcinogenicity
study with sodium oleate, a no observed adverse effect level (NOAEL) could not be identiﬁed but the
substance was considered not to present a carcinogenic potential. Palmitic- and stearic acid which are
the main fatty acids in E 470a and E 470b were already considered of no safety concern in the
re-evaluation of the food additive E 570. The fatty acid moieties of E 470a and E 470b contributed
maximally for 5% to the overall intake of saturated fatty acids from all dietary sources. Overall, the
Panel concluded that there was no need for a numerical ADI and that the food additives sodium,
potassium, calcium and magnesium salts of fatty acids (E 470a and E 470b) were of no safety concern
at the reported uses and use levels.
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Summary
Sodium, potassium and calcium salts of fatty acids (E 470a) and magnesium salts of fatty acids
(E 470b) are authorised as food additives according to Regulation (EC) No 1333/2008 on food additives
and speciﬁc purity criteria have been deﬁned in the Commission Regulation (EU) No 231/2012.
The Scientiﬁc Committee on Food (SCF) established a group acceptable daily intake (ADI) ‘not
speciﬁed’ for the fatty acids (myristic-, stearic-, palmitic- and oleic acid) and their salts in 1991.
In 1974, the Joint FAO/WHO Expert Committee on Food Additives (JECFA) considered that myristic,
palmitic and stearic acid and their salts were normal products of the metabolism of fats and that their
metabolic fate was well established. JECFA further considered that, provided the contribution of the
cations did not add excessively to the normal body load, there was no need to consider the use of these
substances in any different light to that of dietary fatty acids and established an ADI ‘not limited’.
The Panel considered that it is unclear, whether, according to the deﬁnition in the Commission
Regulation 231/2012, the fatty acids or the salts thereof are occurring in food fats and oils. However,
according to the literature, salts of fatty acids are not expected to occur in signiﬁcant amounts in food
fats and oils (low Na, K, Ca or Mg content and acidic conditions due to free fatty acids). Hence, this
evaluation has been performed assuming that only the fatty acids (either free or bound) not the salts
of fatty acids occur in food fats and oils.
According to information from industry, the fatty acids used for the production of sodium,
potassium, calcium and magnesium salts of fatty acids are obtained either from edible (i.e. vegetable
or animal) fats and oils or from distilled food fatty acids. In the Regulation, no indication is given as
regards the chemical nature of the fatty acids or the level at which an individual fatty acid may be
present.
According to information provided by interested parties, salts of fatty acids consist for 95–99% (by
weight) of salts, of which 4–5% account for the cation. In commercial products, the fatty acid fraction
consists at least of 90% stearic- and palmitic acid with a minimum of 40% stearic acid.
The Panel noted that sodium, potassium, calcium and magnesium salts of fatty acids are expected
to dissociate in the gastrointestinal tract into fatty acid carboxylates and their corresponding cations.
The resulting low amounts of sodium, potassium, calcium and magnesium ions will enter normal
physiological processes. Therefore, the properties of the corresponding cations are not discussed
further in the opinion and the Panel considered that a read-across approach could be applied for the
evaluation of the sodium, potassium, calcium and magnesium salts of fatty acids (E 470a and E 470b)
using the previous assessment of the food additive fatty acids (E 570).
The Panel (EFSA ANS Panel, 2017) evaluated the absorption, distribution,. metabolism, excretion
(ADME) of the fatty acids caprylic-, capric-, oleic-, lauric-, palmitic-, myristic- or stearic acid and considered
that they, like other fatty acids, were readily and extensively absorbed from the gastrointestinal tract and
metabolised via the b-oxidation pathway and the tricarboxylic acid cycle to carbon dioxide and excreted.
The Panel noted that the number of toxicological studies on the salts of fatty acids was very
limited.
The Panel considered that:
• As regards genotoxicity, only the mutagenicity studies on calcium caprylate, potassium oleate
and magnesium stearate were available and negative results were obtained. In addition, the
Panel noted that available genotoxicity data for caprylic-, capric-, lauric-, myristic-, palmitic-,
stearic- or oleic acid used as a food additive (E 570) do not raise a concern for genotoxicity.
• As regards carcinogenicity, the Panel noted that in a study in rats, the pancreatic tumours
reported were adenomas not carcinomas; therefore, the Panel considered that sodium oleate
did not present a carcinogenic potential. However, it was not possible to identify a no observed
adverse effect level (NOAEL) from this study.
• No data were available as regards subchronic toxicity, chronic toxicity, reproductive and
developmental toxicity.
However, the EFSA ANS Panel evaluated the safety of the linear free fatty acids caprylic- (C8),
capric- (C10), lauric- (C12), myristic- (C14), palmitic- (C16), stearic- (C18) and oleic acid (C18:1) when
used as a food additive (E 570) and concluded that the use of these acids are of no safety concern at
the reported use and use levels (EFSA ANS Panel, 2017).
For the exposure assessment of E 470a,b, reported uses were available for 24 out of 69 food
categories in which E 470a and E 470b are authorised but only 12 food categories were considered in
the reﬁned exposure scenarios. The Panel noted that the information from the Mintel’s Global New
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Products Database (GNPD) supported the observation that sodium, potassium, calcium and
magnesium salts of fatty acids (E 470a and E 470b) are apparently not used in all food categories in
which the food additives are authorised.
Based on information from the Mintel’s GNPD, the Panel considered that E 470a and E 470b are not
likely to be used in combination in the same food product and, therefore, the exposure assessment of
E 470a and E 470b was performed considering the maximum reported use level (of the maximum and
typical) for either E 470a or E 470b per food category.
As salts of fatty acids are not expected to occur in signiﬁcant amounts in foods, the Panel only
considered the dietary intake of saturated fatty acids as such to assess the contribution of the food
additives (E 470a and E 470b) to the intake of saturated fatty acids via all dietary sources.
Considering that:
• sodium, potassium, calcium and magnesium salts of fatty acids are expected to dissociate in
the gastrointestinal tract to fatty acid carboxylates and their corresponding cations,
• according to information from industry, palmitic acid and stearic acid are the main fatty acids
present in E 470a and E 470b,
• palmitic acid and stearic acid are fatty acids included in the food additive E 570 already
evaluated by the Panel and for which it was concluded that its use was of no safety concern,
• the fatty acid moieties of sodium, potassium, calcium and magnesium salts of fatty acids
(E 470a, E 470b) contributed at the mean maximally 5% to the overall dietary exposure to
saturated fatty acids,
the Panel concluded that there was no need for a numerical ADI and that the food additives sodium,
potassium, calcium and magnesium salts of fatty acids (E 470a and E 470b) were of no safety concern
at the reported uses and use levels.
The Panel recommended that:
• the European Commission considers lowering the current limits for toxic elements (arsenic,
lead, mercury and cadmium) in the European Union speciﬁcations for sodium, potassium and
calcium salts of fatty acids (E 470a) and magnesium salts of fatty acids (E 470b) in order to
ensure that the food additive will not be a signiﬁcant source of exposure to these toxic
elements in food.
• the European Commission considers revising the EU speciﬁcations for sodium, potassium and
calcium salts of fatty acids (E 470a) and magnesium salts of fatty acids (E 470b) including
maximum limits for trans-fatty acids because sodium, potassium and calcium salts of fatty
acids (E 470a) and magnesium salts of fatty acids (E 470b) can be manufactured by
glycerolysis of hydrogenated fats and/or oils, which contain signiﬁcant amounts of trans fatty
acids.
• the European Commission considers revising the EU speciﬁcations for sodium, potassium and
calcium salts of fatty acids (E 470a) and magnesium salts of fatty acids (E 470b) including
maximum limits for erucic acid because as erucic acid can be present among the fatty acids in
edible oils, which can be used for manufacturing of sodium, potassium and calcium salts of
fatty acids (E 470a) and magnesium salts of fatty acids (E 470b).
• the European Commission considers revising the EU speciﬁcations for sodium, potassium and
calcium salts of fatty acids (E 470a) and magnesium salts of fatty acids (E 470b) by rephrasing
the deﬁnition in order to clarify that the fatty acids used as source materials be obtained only
from edible fats and oils.
• in the event that practices reported in this opinion change (e.g. sources of starting material,
uses and use levels), revision of this evaluation would be needed.
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1. Introduction
The present opinion deals with the re-evaluation of the safety of sodium, potassium and calcium
salts of fatty acids (E 470a) and magnesium salts of fatty acids (E 470b) when used as food additives.
1.1. Background and Terms of Reference as provided by the European
Commission
1.1.1. Background
Regulation (EC) No 1333/20081 of the European Parliament and of the Council on food additives
requires that food additives are subject to a safety evaluation by the European Food Safety Authority
(EFSA) before they are permitted for use in the European Union. In addition, it is foreseen that food
additives must be kept under continuous observation and must be re-evaluated by EFSA.
For this purpose, a programme for the re-evaluation of food additives that were already permitted in
the European Union before 20 January 2009 has been set up under the Regulation (EU) No 257/20102.
This Regulation also foresees that food additives are re-evaluated whenever necessary in light of
changing conditions of use and new scientiﬁc information. For efﬁciency and practical purposes, the re-
evaluation should, as far as possible, be conducted by group of food additives according to the main
functional class to which they belong.
The order of priorities for the re-evaluation of the currently approved food additives should be set
on the basis of the following criteria: the time since the last evaluation of a food additive by the
Scientiﬁc Committee on Food (SCF) or by EFSA, the availability of new scientiﬁc evidence, the extent
of use of a food additive in food and the human exposure to the food additive taking also into account
the outcome of the Report from the Commission on Dietary Food Additive Intake in the EU of 2001.
The report ‘Food additives in Europe 2000’ submitted by the Nordic Council of Ministers to the
Commission, provides additional information for the prioritisation of additives for re-evaluation. As
colours were among the ﬁrst additives to be evaluated, these food additives should be re-evaluated
with a highest priority.
In 2003, the Commission already requested EFSA to start a systematic re-evaluation of authorised
food additives. However, as a result of adoption of Regulation (EU) 257/2010 the 2003 Terms of
References are replaced by those below.
1.1.2. Terms of Reference
The Commission asks the EFSA to re-evaluate the safety of food additives already permitted in the
Union before 2009 and to issue scientiﬁc opinions on these additives, taking especially into account the
priorities, procedures and deadlines that are enshrined in the Regulation (EU) No 257/2010 of 25
March 2010 setting up a programme for the re-evaluation of approved food additives in accordance
with the Regulation (EC) No 1333/2008 of the European Parliament and of the Council on food
additives.
1.2. Information on existing authorisations and evaluations
Sodium, potassium and calcium salts of fatty acids (E 470a) and magnesium salts of fatty acids
(E 470b) are authorised as food additives according to Regulation (EC) No 1333/2008 on food additives
and speciﬁc purity criteria have been deﬁned in the Commission Regulation (EU) No 231/20123 for them.
The SCF established a group acceptable daily intake (ADI) ‘not speciﬁed’ for the fatty acids
(myristic-, stearic-, palmitic- and oleic acid) and their salts (SCF, 1991).
The Joint FAO/WHO Expert Committee on Food Additives (JECFA) evaluated the salts of different
fatty acids in the period 1973–2001 (JECFA, 1974, 1984, 1986, 1989, 2001a,b,c). JECFA considered
that myristic, palmitic and stearic acid and their salts were normal products of the metabolism of fats
and that their metabolic fate was well established. JECFA further considered that, provided the
1 Regulation (EC) No 1333/2008 of the European Parliament and of the Council of 16 December 2008 on food additives. OJ L
354, 31.12.2008, p. 16–33.
2 Commission Regulation (EU) No 257/2010 of 25 March 2010 setting up a programme for the re-evaluation of approved food
additives in accordance with Regulation (EC) No 1333/2008 of the European Parliament and of the Council on food additives.
OJ L 80, 26.3.2010, p. 19–27.
3 Commission Regulation (EU) No 231/2012 of 9 March 2012 laying down speciﬁcations for food additives listed in Annexes II
and III to Regulation (EC) no 1333/2008 of the European Parliament and of the Council. OJ L 83, 22.3.2012, p. 1–295.
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contribution of the cations did not add excessively to the normal body load, there was no need to
consider the use of these substances in any different light to that of dietary fatty acids and established
an ADI ‘not limited’ (JECFA, 1974).
Fatty acids and their sodium, potassium, calcium and magnesium salts were also reviewed by the
Nordic Council of Ministers (TemaNord, 2002). The Committee stated that no exhaustive systematic
toxicological studies seemed to have been carried out. However, there was no reason to expect any
health problems when these food additives would be used according to good manufacturing practise.
The EFSA ANS Panel evaluated the safety of the linear free fatty acids caprylic- (C8), capric- (C10),
lauric- (C12), myristic- (C14), palmitic- (C16), stearic- (C18) and oleic acid (C18:1) when used as a
food additive E 570 and concluded that the use of these acids was of no safety concern (EFSA ANS
Panel, 2017).
2. Data and methodologies
2.1. Data
The Panel on Food Additives and Nutrient Sources added to Food (ANS) was not provided with a
newly submitted dossier. EFSA launched public calls for data.4,5
The Panel based its assessment on information submitted to EFSA following the public calls for
data, information from previous evaluations and additional available literature up to January 2018.
Attempts were made at retrieving relevant original study reports on which previous evaluations or
reviews were based however these were not always available to the Panel.
Food consumption data used to estimate the dietary exposure to sodium, potassium and calcium
salts of fatty acids (E 470a) and magnesium salts of fatty acids (E 470b) were derived from the EFSA
Comprehensive European Food Consumption Database (Comprehensive Database.6)
The Mintel’s Global New Products Database (GNPD) was used to verify the use of sodium,
potassium and calcium salts of fatty acids (E 470a) and magnesium salts of fatty acids (E 470b) in
food products. The Mintel’s GNPD is an online database that contains the compulsory ingredient
information present on the label of numerous food products.
2.2. Methodologies
This opinion was formulated following the principles described in the EFSA Guidance on
transparency with regard to scientiﬁc aspects of risk assessment (EFSA Scientiﬁc Committee, 2009)
and following the relevant existing guidance documents from the EFSA Scientiﬁc Committee.
The ANS Panel assessed the safety of sodium, potassium and calcium salts of fatty acids (E 470a)
and magnesium salts of fatty acids (E 470b), in line with the principles laid down in Regulation (EU)
257/2010 and in the relevant guidance documents: Guidance on submission for food additive
evaluations by the SCF (2001).
When the test substance was administered in the feed or in the drinking water, but doses were not
explicitly reported by the authors as mg/kg bw per day based on actual feed or water consumption,
the daily intake was calculated by the Panel using the relevant default values as indicated in the EFSA
Scientiﬁc Committee Guidance document (EFSA Scientiﬁc Committee, 2012) for studies in rodents or,
in the case of other animal species, by JECFA (2000). In these cases, the daily intake is expressed as
‘equivalent’.
Dietary exposure to sodium, potassium and calcium salts of fatty acids (E 470a) and magnesium
salts of fatty acids (E 470b) from their use as food additives was estimated by combining the food
consumption data available within the EFSA Comprehensive Database with the maximum permitted
levels and/or reported use levels submitted to EFSA following a call for data. The exposure was
estimated according to different scenarios (see Section 3.4). Uncertainties in the exposure assessment
were identiﬁed and discussed.
4 Call for scientiﬁc data on food additives permitted in the EU and belonging to the functional classes of emulsiﬁers, stabilisers
and gelling agents. Published: 22 November 2009. Available from: http://www.efsa.europa.eu/en/dataclosed/call/ans091123
5 Call for food additives usage level and/or concentration data in food and beverages intended for human consumption Published
12 October 2015. Available online: http://www.efsa.europa.eu/en/data/call/151012
6 Available online: http://www.efsa.europa.eu/en/datexfoodcdb/datexfooddb.htm
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3. Assessment
3.1. Technical data
3.1.1. Identity of the substance
According to Commission Regulation (EU) No 231/2012, (E 470a) and (E 470b) ‘are sodium,
potassium, calcium and magnesium salts of fatty acids occurring in food oils and fats, salts being
obtained either from edible fats and oils or from distilled food fatty acids’.
According to information provided by industry (APAG, 2016 (Documentation provided to EFSA n.
2)), there are four different origins of the fatty acids used for the production of the additives E 470a
and E 470b: (i) three are derived from vegetable oils, differing in their palmitate/stearate ratio (i.e.
high, medium and low), and (ii) one is derived from animal fat with a high content in stearic acid. It is
further stated that current commercially available salts of fatty acids consist for 95–99% (by weight) of
salts, of which 4–5% account for the metal cation. The fatty acid fraction consists at least of 90%
stearic- and palmitic acid with a minimum of 40% stearic acid. It is stated that other fatty acids such
as lauric acid, myristic acid, pentadecanoic acid, heptanoic acid, oleic acid and arachidic acid may be
present in minor amounts (see Table 1).
The composition and the nature of the fatty acid moieties depend on the source material
(vegetable or animal) used for the production of the food additive and on the selection of the fatty
acid fraction of the distillation, to which the hydrolysed source material was subjected (EFSA ANS
Panel, 2017).
Industry provided analytical data, summarising the composition of 36 commercially available salts of
fatty acids (APAG, 2016 (Documentation provided to EFSA n. 2)). These data are shown in Table 1.
The Panel noted that in the information provided by the individual producers regarding the nature
of most commercially available substances, these substances are described as salts (i.e. Mg-, Ca-, Na-
or K-salts) of stearic acid, whereas, based on the gas–liquid chromatography (GLC) data provided by
APAG, 2016 (Documentation provided to EFSA n. 2), all substances consist of a mixture of salts of
mainly stearic- and palmitic acid (Table 1).
APAG (2016 (Documentation provided to EFSA n. 2)) informed that in one batch of animal-based
fatty acids the following acids also were present: 0.1% ketostearic acid (substance not further
speciﬁed), 0.1% palmitoleic acid (9-cis-hexadecenoic acid; C16H30O2) and 0.2% nonadecanoic acid
(C19H38O2).
In the batches analysed, the amount of total fatty acids other than palmitic or stearic acid ranged
from 0.5% to 8% in the batches analysed.
The chemical identity of the fatty acids present in the commercially available salts of fatty acids –
E 470a and E 470b – is given in Table 2.
Table 1: Fatty acids composition of the commercially available salts of fatty acids as provided by
industry (APAG, 2016 (Documentation provided to EFSA n. 2))
Fatty acids Proportion of fatty acid (%)
Type
Vegetable based
(low palmitate)
Vegetable based
(medium palmitate)
Vegetable based
(high palmitate)
Animal
based
Lauric acid (C12) – 0.0–0.1 0.0–0.6 0.0–1.1
Myristic acid (C14) 0.0–0.3 0.2–0.5 0.0–1.4 1.1–2.3
Pentadecanoic acid
(C15)
– 0.0–0.1 00–1.2 0.2–0.3
Palmitic acid (C16) 30.2–34.2 44.9–45.9 53.5–56.9 28–31
Margaric acid (C17) 0.1–0.2 0.1–0.2 0.2–0.3 0.9–1.0
Stearic acid (C18) 65.1–69.5 52.4–53.7 41.1–44.8 64.2–67.0
Oleic acid (C18:1) 0.0–0.0 0.0–0.1 0.0–0.1 0.0–0.2
Arachidic acid (C20) 0.0–0.7 0.5–0.9 0.4–05 1.3–1.5
Palmitic + stearic
acid (C16 + C18)
98.8–99.5 98.1–99.1 97.1–99.4 92.1–95.2
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The Panel noted that natural fats and oils are always a mixture of fatty acids with a discrete carbon
chain length. Nevertheless, in the analytical data on the composition of the commercially available salts
of fatty acids provided by industry (APAG, 2016 (Documentation provided to EFSA n. 2)), low amounts
of two odd-numbered fatty acids (C15 and C17 compounds) have been reported.
According to Commission Regulation (EU) No 231/2012, sodium and potassium salts of fatty acids
are soluble in water, while calcium and magnesium salts are insoluble in aqueous media. The
Panel noted that, due to their amphipathic (amphiphilic) nature, when dispersed in water, fatty acid
salts partially or totally dissolve (depending on their solubility and concentration) and tend to form
micelles (Alberts et al., 2002).
3.1.2. Speciﬁcations
Speciﬁcations for the sodium, potassium and calcium salts of fatty acids (E 470a) and for the
magnesium salts (E 470b) are deﬁned in Commission Regulation (EU) No 231/1012. According to
Table 2: Identity of the fatty acids present in commercially available E 470a and E 470b as listed in
Table 1
Fatty acid
(common
name)
Fatty acid
(systematic
name)
Structural
formula of
fatty acid
anion
CAS registry
number acid/
EINECS number
Salt
cation
CAS
registry
number
EINECS
(EC number)
Lauric acid
(C12)
Dodecanoic acid CH3–(CH2)10–
COO
143-07-7/205-582-1 Na+ 629-25-4 211-082-4
K+ 10124-65-9 233-344-7
1/2 Ca2+ 4696-56-4 225-166-3
1/2 Mg2+ 4040-48-6 223-727-7
Myristic acid
(C14)
Tetradecanoic acid CH3–(CH2)12–
COO
544-63-8/208-875-2 Na+ 822-12-8 212-487-9
K+ 13429-27-1 236-550-5
1/2 Ca2+ 15284-51-2 239-328-6
1/2 Mg2+ 4086-70-8 223-817-6
Pentadecylic
acid (C15)
Pentadecanoic acid CH3–(CH2)13–
COO
1002-84-2/213-693-
1
Na+ 4268-63-7 224-255-4
K+ 17378-35-7 241-415-9
1/2 Ca2+ 4499-92-7 224-802-7
1/2 Mg2+ 93966-75-7 301-028-9
Palmitic acid
(C16)
Hexadecanoic acid CH3–(CH2)14–
COO
57-10-3/200-312-9 Na+ 408-35-5 206-988-1
K+ 2624-31-9 220-088-6
1/2 Ca2+ 542-42-7 208-811-3
1/2 Mg2+ 2601-98-1 220-010-0
Margaric acid
(C17)
Heptadecanoic acid CH3–(CH2)15–
COO
506-12-7/208-027-1 Na+ 1002-82-0 213-692-6
K+ 17378-36-8 241-416-4
1/2 Ca2+ 4499-95-0 224-804-8
1/2 Mg2+ 94266-34-9 304-441-2
Stearic acid
(C18)
Octadecanoic acid CH3–(CH2)16–
COO
57-11-4/200-313-4 Na+ 822-16-2 212-490-5
K+ 593-29-3 209-786-1
1/2 Ca2+ 1592-23-0 216-472-8
1/2 Mg2+ 557-04-0 209-150-3
Oleic acid
(C18:1)
cis-9-octadecenoic
acid
CH3–(CH2)7–
CH=CH–
(CH2)7–COO

112-80-1/204-007-1 Na+ 143-19-1 205-591-0
K+ 143-18-0 205-590-5
1/2 Ca2+ 142-17-6 205-525-0
1/2 Mg2+ 1555-53-9 216-303-8
Arachidic acid
(C20)
n-eicosanoic acid CH3–(CH2)18–
COO
506-30-9//208-031-
3
Na+ 13257-34-6 236-248-3
K+ 18080-76-7 241-990-6
1/2 Ca2+ 22302-43-8 244-900-3
1/2 Mg2+ 57593-01-8 260-840-0
CAS: Chemical Abstracts Service; EINECS: European Inventory of Existing Chemical Substances.
Re-evaluation of E 470a and E 470b as food additives
www.efsa.europa.eu/efsajournal 9 EFSA Journal 2018;16(3):5180
JECFA, speciﬁcations for sodium, potassium and calcium salts of fatty acids (INS No 470) and for
magnesium distearate (INS No 470(iii)) are available (Table 3).
Table 3: Speciﬁcations for sodium, potassium and calcium salts of fatty acids (E 470a) according to
Commission Regulation (EU) No 231/2012 and JECFA (2006), and for magnesium salts of
fatty acids (E 470b) according to Commission Regulation (EU) No 231/2012 and
magnesium distearate (JECFA, 2015)
Sodium, potassium
and calcium salts of
fatty acids (E 470a)
Magnesium
salts of fatty
acids (E 470b)
Salts of fatty acids
(INS No 470)
Magnesium distearate,
dibasic magnesium
stearate, INS No 470(iii)
Commission
Regulation (EU)
No 231/2012
Commission
Regulation
(EU) No
231/2012
JECFA (2006) JECFA (2015)
Deﬁnition Sodium, potassium
and calcium salts of
fatty acids occurring in
food oils and fats,
these salts being
obtained either from
edible fats and oils or
from distilled food
fatty acids
Magnesium salts
of fatty acids
occurring in food
oils and fats,
these salts being
obtained either
from edible fats
and oils or from
distilled food
fatty acids
These products consist
of calcium, potassium
or sodium salts of
commercial myristic,
oleic, palmitic, stearic,
acids or mixtures of
these acids from
edible fats and oils.
The article of
commerce can be
further speciﬁed by:
• saponiﬁcation
value,
• solidiﬁcation point
for the fatty acids
obtained from the
salts,
• iodine value,
• residue on
ignition including
assay of the
cation, and
• moisture content
Magnesium stearate is a
mixture of magnesium salts
of fatty acids obtained from
edible fats and oils. The
product consists mainly of
magnesium stearate and
palmitate in varying
proportions. It is
manufactured by one of the
two following processes: (a)
direct process wherein fatty
acids are directly reacted
with a magnesium source,
such as magnesium oxide to
form magnesium salts of the
fatty acids; (b) indirect
process where a sodium
soap is produced by the
reaction of fatty acids with
sodium hydroxide in water
and the product is
precipitated by adding
magnesium salts to the
soap
Assay Content on the
anhydrous basis not
less than 95% (105°C
till a constant weight)
Content on the
anhydrous basis
not less than
95% (105°C till
a constant
weight)
Not less than 95%
total fatty acid salts,
dry weight basis
Description White or creamy white
light powders, ﬂakes
or semi-solids
White or creamy
white light
powders, ﬂakes
or semi-solids
Hard, white or faintly
yellowish, somewhat
glossy and crystalline
solids or semi-solids or
white or yellowish-
white powder
Identiﬁcation
Solubility Sodium and potassium
salts: soluble in water
and ethanol
Calcium salts: insoluble
in water, ethanol and
ether
Insoluble in
water, partially
soluble in
ethanol and
ether
Potassium and sodium
salts are soluble in
water and ethanol;
calcium salts are
insoluble in water,
ethanol and ether
Practically insoluble in water
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Sodium, potassium
and calcium salts of
fatty acids (E 470a)
Magnesium
salts of fatty
acids (E 470b)
Salts of fatty acids
(INS No 470)
Magnesium distearate,
dibasic magnesium
stearate, INS No 470(iii)
Test for cations Passes test – Heat 1 g of the
sample with a mixture
of 25 mL of water and
5 mL of hydrochloric
acid. Fatty acids are
liberated, ﬂoating as a
solid or oil layer on the
surface which is
soluble in hexane.
After cooling, aqueous
layer is decanted and
evaporated to dryness.
Dissolve the residue in
water and test for the
appropriate cation
Test for
magnesium
– Passes test – Using the Method of Assay,
identify presence of
magnesium in the sample
Test for fatty
acids
Passes test Passes test Using the Method of
Assay, identify the
individual fatty sample.
The fatty acid(s) in
primary abundance
should conform to
those declared on the
label of the product
Purity
Sodium Not less than 9% and
not more than 14%
expressed as Na2O
– –
Potassium Not less than 13% and
not more than 21.5%
expressed as K2O
– –
Calcium Not less than 8.5%
and not more than
13% expressed as
CaO
– –
Magnesium – Not less than
6.5% and not
more than 11%
expressed as
MgO
– Not less than 4.0% and not
more than 5.0%, on dried
basis
Unsaponiﬁable
matter
Not more than 2% Not more than
2%
Not more than 2% Not more than 2%
Free fatty acids Not more than 3%
estimated as oleic acid
Not more than
3% estimated as
oleic acid
Not more than 3%
Measure free fatty
acids as directed in the
method Free Fatty
Acids. Compute free
fatty acid content
using an equivalence
factor (e) equal to
1/10th the molecular
weight of the salt
Not less than 40.0% stearic
acid in the fatty acid
fraction; and not less than
90.0% as the sum of stearic
acid and palmitic acid in the
fatty acid fraction
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The Panel considered that it is unclear, whether, according to the deﬁnition in the Regulation
231/2012, the fatty acids or the salts thereof are occurring in food fats and oils. However, according
to the literature, salts of fatty acids are not expected to occur in signiﬁcant amounts in food fats
and oils (low Na, K, Ca or Mg content and acidic conditions due to free fatty acids). Therefore, this
evaluation has been performed assuming that only the fatty acids (either free or bound) not the
salts of fatty acids occur in food fats and oils.
The Panel noted that in Commission Regulation (EU) No 231/2012, the term ‘distilled food fatty
acids’ is used. In the view of the Panel this term should be more clearly described. Indeed, without
any further speciﬁcation of this term, fatty acids that are identical to those present in foods, but that
are produced by distillation from non-food sources, could also be used as source material for the
production of the food additives E 470a and E 470b. The Panel considered that the safety of use of
salts of fatty acids produced using fatty acids, obtained via distillation from non-food sources cannot
be assessed. Therefore, the use of these sources should be avoided.
The Panel noted that, according to the EU speciﬁcations for E 470a and E 470b, impurities of the
toxic elements arsenic, cadmium, lead and mercury are accepted up to concentrations of 3, 2, 1 and
1 mg/kg, respectively. Contamination at these levels could have a signiﬁcant impact on the exposure to
these toxic elements, which are already close to the health-based guidance values or benchmark doses
(lower conﬁdence limits) established by EFSA (EFSA CONTAM Panel, 2009a,b, 2010, 2012a,b,c, 2014).
According to information provided by industry (APAG, 2016 (Documentation provided to EFSA n.
2)), nickel present in the starting material could be a potential impurity in the ﬁnal product. The
Panel noted that no maximum limit for nickel is included in the EU speciﬁcations for E 470a and
E 470b, although it is included in JECFA speciﬁcations for magnesium distearate.
According to EU speciﬁcations, E 470a and E 470b can be manufactured by using food oils and
fats. Beside natural oils and fats, also hydrogenated fats and or oils can be used for manufacturing of
E 470a and E 470b.
According to EFSA (EFSA NDA Panel, 2004), industrial hydrogenation (used to produce semi-solid
and solid fats that can be used for the production of foods such as margarines, shortenings, and
Sodium, potassium
and calcium salts of
fatty acids (E 470a)
Magnesium
salts of fatty
acids (E 470b)
Salts of fatty acids
(INS No 470)
Magnesium distearate,
dibasic magnesium
stearate, INS No 470(iii)
Arsenic Not more than
3 mg/kg
Not more than
3 mg/kg
–
Lead Not more than
2 mg/kg
Not more than
2 mg/kg
Not more than
2 mg/kg
Determine using an
atomic absorption
technique appropriate
to the speciﬁed level.
The selection of
sample size and
method of sample
preparation may be
based on the principles
of the method
described in Volume 4,
‘Instrumental Methods’
Not more than 2 mg/kg
Mercury Not more than
1 mg/kg
Not more than
1 mg/kg
–
Cadmium Not more than
1 mg/kg
Not more than
1 mg/kg
– Not more than 1 mg/kg
Nickel Not more than 3 mg/kg
Free alkali Not more than
0.1% expressed
as NaOH
Not more than
0.1% expressed
as MgO
–
Matter insoluble
in alcohol
Not more than
0.2% (sodium and
potassium salts only)
– –
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biscuits) and deodorisation (a necessary step in reﬁning) of unsaturated vegetable oils high in
polyunsaturated fatty acids is one of the three main pathways for the formation of trans fatty acids in
food. According to EFSA (EFSA NDA Panel, 2010), higher intakes of trans-fatty acids have consistently
been found to be associated with an increased risk of coronary heart disease and it was recommended
that trans fatty acids intake should be as low as possible within the context of a nutritionally adequate
diet. The Panel noted that there is no limit for trans fatty acids in the speciﬁcations for E 470a and
E 470b.
According to the EU speciﬁcations for E 470a and E 470b, rapeseed oil, which contains erucic acid,
could be used for the manufacturing E 470a and E 470b according to their EU speciﬁcations. Maximum
levels for erucic acid have been established in EU according to Commission Regulation (EU)
No 696/20147 in edible oils and fats as well as in food containing fats and oils. A tolerable daily intake
(TDI) of 7 mg/kg body weight (bw) per day for erucic acid has been established by the EFSA CONTAM
Panel based on a no observed adverse effect level (NOAEL) of 700 mg/kg bw per day for myocardial
lipidosis observed in a 7-day feeding study in young (5–7 weeks) rats and in a 2-week feeding study in
newborn piglets (EFSA CONTAM Panel, 2016). The Panel noted that there are no limits for erucic acid
in the current EU speciﬁcations E 470a and E 470b.
The Panel noted that there is a maximum limit set for sum of dioxins in Regulation (EC) 1881/2006
(Section 5) for marine oils (5.7), fat of bovine animals and sheep, poultry and pigs (5.10), mixed
animal fat (5.11) and vegetable oils and fats (5.12).
3.1.3. Manufacturing process
According to information provided by industry (APAG, 2016 (Documentation provided to EFSA n. 2)),
the sodium, potassium, calcium and magnesium salts of fatty acids (E 470a, E 470b) are commonly
manufactured by one of two of the following processes: a ‘direct process’ or a ‘precipitation process’.
Direct process
In this process, fatty acids are neutralised to yield a speciﬁc salt of fatty acids. As cation sources,
oxides (magnesium or calcium oxide) or hydroxides (sodium-, potassium-, magnesium- or calcium
hydroxide) may be used.
General reaction equation:
fatty acidþmetal oxide/hydroxide! metal fatty acid saltþ water
Precipitation process
This process consists of two consecutive steps. In a ﬁrst step, a sodium soap is produced by the
reaction of the fatty acids with sodium hydroxide in water. In the second step, the salts of fatty acids
are precipitated by adding the required metal cation salt.
General reaction equations:
Step 1: fatty acidþ NaOH! Fatty acid sodium saltþwater
Step 2: fatty acid sodium saltþ X2þ ! X(fatty acid)2 þ 2Naþ
X2+: being Ca2+ or Mg2+
Nature of raw materials used in the manufacturing processes
In Commission Regulation (EU) No 231/2012, it is stated that the salts of fatty acids are obtained
either from edible fats and oils or from distilled food fatty acids.
According to information provided by industry (APAG, 2016 (Documentation provided to EFSA n.
2)), the fatty acids used for the manufacturing of all four salts are derived from edible fats and oils.
They are obtained from either vegetable sources (e.g. palm oil) or animal sources such as food grade
lard and tallows (e.g. lard, suet or bone fat from beef and pigskin fat). It is stated that the fatty acids
derived from edible fats and oils consist mainly of stearic or palmitic acid.
7 Commission Regulation (EU) No 694/2014 of 24 June 2014 amending Regulation (EC) No 1881/2006 as regards maximum
levels of erucic acid in vegetable oils and fats and foods containing vegetable oils and fats. OJ L 184, 25.6.2014, p. 1–2.
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3.1.4. Methods of analysis in food
For the method of analysis, interested parties (APAG, 2016 (Documentation provided to EFSA n. 2))
referred to the procedure described in the JECFA method (JECFA, 2006). The method involves
esteriﬁcation by methanol of the fatty acids in the presence of boron triﬂuoride and alkaline conditions.
The fatty acid methyl esters are subsequently analysed by GLC and the percentage area of the fatty
acids in the chromatogram is calculated.
The Panel presented an overview of methods for the analysis of individual fatty acids in food in the
re-evaluation of fatty acids (E 570) as a food additive (EFSA ANS Panel, 2017).
3.1.5. Reaction and fate in food
Metal salts of saturated fatty acids are stable products for which no decomposition products are
expected under normal storage conditions (Rustan and Drevon, 2005). Auto-oxidation products can
typically be present in unsaturated fatty acids (Belitz et al., 2008) and are not expected to be found in
saturated fatty acids such as stearic acid and palmitic acid. According to APAG (2016 (Documentation
provided to EFSA n. 2)), a moisture uptake during longer storage (> 12 months) may take place.
3.2. Authorised uses and use levels
Maximum levels of sodium, potassium, calcium and magnesium salts of fatty acids (E 470a, E 470b)
have been deﬁned in Annex II to Regulation (EC) No 1333/20088 on food additives, as amended. In
this opinion, these levels are named maximum permitted levels (MPLs).
Currently, sodium, potassium, calcium and magnesium salts of fatty acids (E 470a, E 470b) are
authorised as Group I food additive in 67 food categories and have a speciﬁc authorised use in only
two food categories (of which one has only an authorisation for E 470a). E 470a and E 470b are
authorised at quantum satis (QS) in all food categories. Table 4 summarises foods that are permitted
to contain E 470a or E 470b as set by Annex II to Regulation (EC) No 1333/2008.
Table 4: MPLs of E 470a and E 470b in foods according to Annex II to Regulation (EC) No 1333/2008
Food
category
number
Food category name
E-number/
group
Restrictions/
exception
MPL (mg/L or mg/kg
as appropriate)
1.3 Unﬂavoured fermented milk
products, heat-treated after
fermentation
Group I quantum satis
1.4 Flavoured fermented milk products
including heat-treated products
Group I quantum satis
01.6.3 Other creams Group I quantum satis
01.7.1 Unripened cheese excluding
products falling in category 16
Group I Except mozzarella quantum satis
01.7.5 Processed cheese Group I quantum satis
01.7.6 Cheese products (excluding
products falling in category 16)
Group I quantum satis
1.8 Dairy analogues, including
beverage whiteners
Group I quantum satis
02.2.2 Other fat and oil emulsions
including spreads as deﬁned by
Council Regulation (EC) No
1234/2007 and liquid emulsions
Group I quantum satis
2.3 Vegetable oil pan spray Group I quantum satis
3 Edible ices Group I quantum satis
04.2.1 Dried fruit and vegetables Group I quantum satis
04.2.2 Fruit and vegetables in vinegar, oil,
or brine
Group I quantum satis
8 Commission Regulation (EC) No 1333/2008 of the European Parliament and of the Council of 16 December 2008 on food
additives. OJ L 354, 31.12.2008, p. 16.
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Food
category
number
Food category name
E-number/
group
Restrictions/
exception
MPL (mg/L or mg/kg
as appropriate)
04.2.4.1 Fruit and vegetables preparations
excluding compote
Group I quantum satis
04.2.5.4 Nut butters and nut spreads Group I quantum satis
04.2.6 Processed potato products Group I quantum satis
5.1 Cocoa and Chocolate products as
covered by Directive 2000/36/EC
Group I Only energy-reduced
or with no added
sugar
quantum satis
5.2 Other confectionery including
breath freshening microsweets
Group I quantum satis
5.3 Chewing gum Group I quantum satis
5.4 Decorations, coatings and ﬁllings,
except fruit-based ﬁllings covered
by category 4.2.4
Group I quantum satis
6.2.2 Starches Group I quantum satis
6.3 Breakfast cereals Group I quantum satis
6.4.2 Dry pasta Group I Only gluten free and/
or pasta intended for
hypoproteic diets in
accordance with
Directive 2009/39/EC
quantum satis
6.4.4 Potato gnocchi Group I Except fresh
refrigerated potato
gnocchi
quantum satis
6.4.5 Fillings of stuffed pasta (ravioli and
similar)
Group I quantum satis
6.5 Noodles Group I quantum satis
6.6 Batters Group I quantum satis
6.7 Pre-cooked or processed cereals Group I quantum satis
7.1 Bread and rolls Group I Except products in
7.1.1 and 7.1.2
quantum satis
7.2 Fine bakery wares Group I quantum satis
8.3.1 Non-heat-treated meat products Group I quantum satis
8.3.2 Heat- treated meat products Group I Except foie gras, foie
gras entier, blocs de
foie gras, libamaj,
libamaj egeszben,
libamaj t€ombben
quantum satis
8.3.3 Casings and coatings and
decorations for meat
Group I quantum satis
9.2 Processed ﬁsh and ﬁshery
products including molluscs and
crustaceans
Group I quantum satis
9.3 Fish roe Group I Only processed ﬁsh
roe
quantum satis
10.2 Processed eggs and egg products Group I quantum satis
11.2 Other sugars and syrups Group I quantum satis
11.4.3 Table-top sweeteners in tablets E 470a
E 470b
quantum satis
12.1.2 Salt substitutes Group I quantum satis
12.2.1 Herbs and Spices E 470a Only when dried quantum satis
12.2.2 Seasonings and condiments Group I quantum satis
12.3 Vinegars Group I quantum satis
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Food
category
number
Food category name
E-number/
group
Restrictions/
exception
MPL (mg/L or mg/kg
as appropriate)
12.4 Mustard Group I quantum satis
12.5 Soups and broths Group I quantum satis
12.6 Sauces Group I quantum satis
12.7 Salads and savoury-based
sandwich spreads
Group I quantum satis
12.8 Yeast and yeast products Group I quantum satis
12.9 Protein products, excluding
products covered in category 1.8
Group I quantum satis
13.2 Dietary foods for special medical
purposes deﬁned in Directive
1999/21/EC (excluding products
from food category 13.1.5)
Group I quantum satis
13.3 Dietary foods for weight control
diets intended to replace total daily
food intake or an individual meal
(the whole or part of the total
daily diet)
Group I quantum satis
13.4 Foods suitable for people
intolerant to gluten as deﬁned by
Regulation (EC) No 41/2009
Group I Including dry pasta quantum satis
14.1.2 Fruit juices as deﬁned by Directive
2001/112/EC and vegetable juices
Group I Only vegetable juices quantum satis
14.1.3 Fruit nectars as deﬁned by
Directive 2001/112/EC and
vegetable nectars and similar
products
Group I Only vegetable nectars quantum satis
14.1.4 Flavoured drinks Group I quantum satis
14.1.5.2 Other Group I Excluding unﬂavoured
leaf tea; including
ﬂavoured instant
coffee
quantum satis
14.2.3 Cider and perry Group I quantum satis
14.2.4 Fruit wine and made wine Group I quantum satis
14.2.5 Mead Group I quantum satis
14.2.6 Spirit drinks as deﬁned in
Regulation (EC) No 110/2008
Group I Except whisky or
whiskey
quantum satis
14.2.7.1 Aromatised wines Group I quantum satis
14.2.7.2 Aromatised wine-based drinks Group I quantum satis
14.2.7.3 Aromatised wine-product cocktails Group I quantum satis
14.2.8 Other alcoholic drinks including
mixtures of alcoholic drinks with
non-alcoholic drinks and spirits
with less than 15% of alcohol
Group I quantum satis
15.1 Potato-, cereal-, ﬂour- or starch-
based snacks
Group I quantum satis
15.2 Processed nuts Group I quantum satis
16 Desserts excluding products
covered in category 1, 3 and 4
Group I quantum satis
17.1(a) Food supplements supplied in a
solid form including capsules and
tablets and similar forms,
excluding chewable forms
Group I quantum satis
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According to Annex III, Part 1 of Regulation (EC) No 1333/2008, sodium, potassium and calcium
salts of fatty acids (E 470a) is authorised as carrier of glazing agents for fruits with a maximum level
at QS and magnesium salts of fatty acids (E 470b) is also authorised as carrier of colours and fat
soluble antioxidants with a maximum level at QS.
According to Annex III, Part 2 of Regulation (EC) No 1333/2008, sodium, potassium, calcium and
magnesium salts of fatty acids (E 470a, E 470b) are also authorised as food additives having a
function other than carriers in food additive preparations with a maximum level at QS.
According to Annex III, Part 3 of Regulation (EC) No 1333/2008, sodium, potassium, calcium and
magnesium salts of fatty acids (E 470a, E 470b) are authorised as food additives in food enzymes with
a maximum level in the enzyme preparation and in ﬁnal foods including beverages at QS.
According to Annex III, Part 4 of Regulation (EC) No 1333/2008, sodium, potassium, calcium and
magnesium salts of fatty acids (E 470a, E 470b) are authorised as in food ﬂavourings with a maximum
level at QS.
In addition, according to Annex III, Part 5, Section A of Regulation (EC) No 1333/2008, sodium,
potassium, calcium and magnesium salts of fatty acids (E 470a, E 470b) are authorised as food
additives in all nutrients, except those intended to be used in foodstuffs for infants and young children
listed in point 13.1 of Part E of Annex II, at QS.
3.3. Exposure assessment
3.3.1. Reported use levels of E 470a and E 470b
Most food additives in the EU are authorised at a speciﬁc MPL. However, a food additive may be
used at a lower level than the MPL. Therefore, information on actual use levels is required for
performing a more realistic exposure assessment, especially for those food additives for which no MPL
is set and which are authorised at QS.
In the framework of Regulation (EC) No 1333/2008 on food additives and of Commission
Regulation (EU) No 257/2010 regarding the re-evaluation of approved food additives, EFSA issued a
public call9 for occurrence data (usage level and/or analytical data) on sodium, potassium, calcium and
magnesium salts of fatty acids (E 470a, E 470b). In response to this public call, updated information
on the actual use levels of sodium, potassium, calcium and magnesium salts of fatty acids (E 470a,
E 470b) in foods was made available to EFSA by industry. No analytical data of these food additives in
foods were made available by the Member States.
Summarised data on reported use levels in foods provided by industry
Industry provided EFSA with data on use levels (n = 373) of sodium, potassium, calcium and magnesium
salts of fatty acids (E 470a, E 470b) in 24 food categories out of the 69 in which the additives are authorised.
In particular, a total of 38 use levels were provided for E 470a in 20 food categories and 335 use levels
for E 470b in 15 food categories. For E 470b, the majority (208 out of 335) of the use levels reported
were for FC 17.1 (Food supplements supplied in a solid form including capsules and tablets and similar
forms, excluding chewable forms). For 11 food categories, use levels for both additives were provided.
Food
category
number
Food category name
E-number/
group
Restrictions/
exception
MPL (mg/L or mg/kg
as appropriate)
17.2(a) Food supplements supplied in a
liquid form
Group I quantum satis
17.3(a) Food supplements supplied in a
syrup-type or chewable form
Group I quantum satis
18 Processed foods not covered by
categories 1 to 17, excluding foods
for infants and young children
Group I quantum satis
MPL: maximum permitted level.
(a): FCS 17 refers to food supplements as deﬁned in Directive 2002/46/EC of the European Parliament and of the Council
excluding food supplements for infants and young children.
9 https://www.efsa.europa.eu/de/data/call/151012
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Updated information on the actual use levels of E 470a and E 470b in foods was made available to
EFSA by the Association of the European Self-Medication Industry (AESGP), Dr Loges Naturheilkunde
neu entdecken (LOGES), European federation of Associations of Health Products Manufacturers (EHPM),
Food Drink Europe (FDE), Food Supplements Europe (FSE), International Chewing Gum Association
(ICGA), International Food Additives Council (IFAC), KR€UGER GmbH & Co. and Saqual GmbH.
The Panel noted that some data providers of use levels of E 470a and E 470b, namely Saqual GmbH
and IFAC, were not food industries using E 470a or E 470b in food products, but food additive producers
or representatives of food additive producers. Usage levels reported by these parties could not be
considered in the same way as those provided by food industry, because food additive producers might
recommend usage levels to the food industry, but the ﬁnal levels in the food products may be quite
different. Because, Saqual GmbH and IFAC did not conﬁrm that the recommended levels were used by
the food industry, their data were not considered in the reﬁned exposure scenarios. Data from food
additive producers were only used in the maximum level exposure assessment scenario in case of QS
authorisation when no data were available from food industry or Member States. For E 470a and E 470b,
only data from food additive producers were available for FC 03 (Edible Ices), FC 11.2 (Other sugars and
syrups), FC 12.2.1 (Herbs and spices), FC 12.2.2 (Seasonings and Condiments), FC 12.6 (Sauces) and
FC 12.8 (Yeast and yeast products). These data were therefore only used in the maximum level
exposure assessment scenario. In the reﬁned scenarios, these six food categories were not considered.
The Panel noted that the use levels provided for 26 food products referred to niche products10 in the
following food categories: FC 03 (Edible ices), FC 05.3 (Chewing gum), FC 07.2 (Fine bakery wares), FC
17.1 (Food supplements supplied in a solid form including capsules and tablets and similar forms,
excluding chewable forms) and FC 17.3 (Food supplements supplied in a solid form including capsules
and tablets and similar forms, excluding chewable forms). These niche levels were considered in the
maximum level exposure assessment scenario. In the reﬁned scenarios, use levels of niche products
were only considered when no use levels of more widely consumed foods were available within the
corresponding food category. This was the case for the use levels for FC 05.3 (Chewing gum). For FC
03 (Edible ices), the only use level was also related to a niche product; however, because this use level
was reported by an food additive producer, it was not considered in the reﬁned scenarios.
Appendix A provides data on the use levels of E 470a and E 470b in foods as reported by industry.
3.3.2. Summarised data extracted from the Mintel’s Global New Products
Database
The Mintel’s GNPD is an online database which monitors new introductions of packaged goods in
the market worldwide. It contains information on over 2.5 million food and beverage products of
which more than 900,000 are or have been available on the European food market. The Mintel’s GNPD
started covering EU’s food markets in 1996, currently having 20 out of its 28 member countries and
Norway presented in the Mintel’s GNPD.11
For the purpose of this Scientiﬁc Opinion, the Mintel’s GNPD12 was used to check the labelling of
food and beverage products, including food supplements, for E 470a and E 470b within the EU’s food
market as the database contains the compulsory ingredient information on the label.
According to the Mintel’s GNPD, E 470a was labelled on 329 products published in this database
between January 2012 and August 2017. These foods belonged to 39 food subcategories of the
Mintel’s GNPD. The top-4 subcategories in term of number of products containing E 470a were Cakes,
Pastries & Sweet Goods (n = 103), Vitamins & Dietary Supplements (n = 37), Dairy Based Ice Cream &
Frozen Yogurt (n = 14) and Chilled Desserts (n = 14). When considering the percentage of foods
containing E 470a according to the label per food subcategory, the top-4 subcategories were Other
Natural Sweeteners (1.6%), Standard & Power Mints (1.2%), Frozen Desserts (0.8%) and Cakes,
Pastries & Sweet Goods (0.7%). Overall according to the indication of the label, 0.1% of the products,
which are present in the Mintel’s GNPD contained E 470a.
E 470b was present in 3,324 products covering 26 food subcategories during the same period. The
top-4 subcategories in terms of number of products containing E 470b were Vitamins & Dietary
Supplements (n = 2,532), Standard & Power Mints (n = 335), Other Sugar Confectionery (n = 159)
and Medicated Confectionery (n = 61). When considering the percentage of products containing
E 470b according to the label per food subcategory, the top-4 subcategories were Standard & Power
10 Whether a use level is applicable to a niche product is provided by industry.
11 Missing Bulgaria, Cyprus, Estonia, Latvia, Lithuania, Luxembourg, Malta and Slovenia.
12 http://www.gnpd.com/sinatra/home/ accessed on 21/8/2017.
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Mints (40.6%), Vitamins & Dietary Supplements (29.6%), Mixed Assortments (13.3%) and Other
Sugar Confectionery (12.9%). Overall, according to the indication of the label, 0.7% of the products,
which are present in the Mintel’s GNPD contained E 470b.
Only one food (sponge cake in food sub-category Cakes, Pastries & Sweet Goods) was reported to
contain a combination of E 470a and E 470b.
Appendix B lists the number and percentage of products labelled with E 470a and/or E 470b
between January 2012 and August 2017, out of the total number of products per food subcategories
according to the Mintel’s GNPD food classiﬁcation.
According to the Mintel’s GNPD, E 470a and E 470b are also used in food and beverage products in
the following food subcategories (covering 26 food products), whereas no information on usage levels
was available for the corresponding food categories:
• 01.3 Unﬂavoured fermented milk products, heat-treated after fermentation,
• 01.7.1 Unripened cheese excluding products falling in category 16,
• 04.2.4.1 Fruit and vegetables preparations excluding compote,
• 04.2.6 Processed potato products,
• 09.2 Processed ﬁsh and ﬁshery products including molluscs and crustaceans,
• 10.2 Processed eggs and egg products,
• 12.7 Salads and savoury-based sandwich spreads,
• 8.3.2 Heat-treated meat products
• 8.3.3 Casings and coatings and decorations for meat.
This may have resulted in an underestimation of the exposure.
3.3.3. Food consumption data used for exposure assessment
EFSA Comprehensive European Food Consumption Database
Since 2010, the EFSA Comprehensive European Food Consumption Database (Comprehensive
Database) has been populated with national data on food consumption at a detailed level. Competent
authorities in the European countries provide EFSA with data on the level of food consumption by the
individual consumer from the most recent national dietary survey in their country (cf. Guidance of
EFSA on the ‘Use of the EFSA Comprehensive European Food Consumption Database in Exposure
Assessment’ (EFSA, 2011a). New consumption surveys added in the Comprehensive database in 2015
were also taken into account in this assessment.6
The food consumption data gathered by EFSA were collected by different methodologies and thus
direct country-to-country comparisons should be interpreted with caution. Depending on the food
category and the level of detail used for exposure calculations, uncertainties could be introduced owing
to possible subjects’ underreporting and/or misreporting of the consumption amounts. Nevertheless,
the EFSA Comprehensive Database includes the currently best available food consumption data across
Europe.
Food consumption data from the following population groups were used for the exposure
assessment: infants, toddlers, children, adolescents, adults and the elderly. For the present
assessment, food consumption data were available from 33 different dietary surveys carried out in 19
European countries (Table 5).
Table 5: Population groups considered for the exposure estimates of sodium, potassium and
calcium salts of fatty acids (E 470a) and magnesium salts of fatty acids (E 470b)
Population Age range
Countries with food consumption surveys covering more
than 1 day
Infants From more than 12 weeks
up to and including
11 months of age
Bulgaria, Denmark, Finland, Germany, Italy, UK
Toddlers(a) From 12 months up to and
including 35 months of age
Belgium, Bulgaria, Denmark, Finland, Germany, Italy, Netherlands,
Spain, UK
Children(b) From 36 months up to and
including 9 years of age
Austria, Belgium, Bulgaria, Czech Republic, Denmark, Finland,
France, Germany, Greece, Italy, Latvia, Netherlands, Spain,
Sweden, UK
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Consumption records were codiﬁed according to the FoodEx classiﬁcation system (EFSA, 2011b).
Nomenclature from the FoodEx classiﬁcation system has been linked to the food categorisation system
(FCS) as presented in Annex II of Regulation (EC) No 1333/2008, part D, to perform exposure
estimates. In practice, the FoodEx food codes were matched to the FCS food categories.
Food categories considered for the exposure assessment of sodium, potassium and
calcium salts of fatty acids (E 470a) and magnesium salts of fatty acids (E 470b)
The food categories for which use level of sodium, potassium and calcium salts of fatty acids
(E 470a) and magnesium salts of fatty acids (E 470b) were provided, were selected from the
nomenclature of the EFSA Comprehensive Database (FoodEx classiﬁcation system), at the most
detailed level possible (up to FoodEx Level 4) (EFSA, 2011b).
Some food categories are not referenced in the EFSA Comprehensive Database and could therefore
not be taken into account in the present estimate. This was the case for FC 12.1.2 Salt substitutes
(Appendix C). Not considering this food category may have resulted in an underestimation of the
exposure.
Moreover, for the following food categories, the restrictions/exceptions which apply to the use of
sodium, potassium and calcium salts of fatty acids (E 470a) and magnesium salts of fatty acids
(E 470b) could not be taken into account, and therefore the whole food category was considered in
the exposure assessment. This applies to three food categories (Appendix C) and may have resulted in
an overestimation of the exposure:
• 5.1 Cocoa and Chocolate products as covered by Directive 2000/36/EC (E 470a and E 470b
only permitted in energy-reduced products or products with no added sugar)
• 7.1 Bread and rolls (E 470a and E 470b not allowed in foods belonging to FCs 7.1.1 and 7.1.2)
• 12.2.1 Herbs and Spices (E 470a only allowed in the dried forms of these foods).
In addition, the restrictions which apply to the use of E 470a and E 470b for the FCs 17.1, 17.2 and
FC 17.3 (Food supplements, in solid, liquid and syrup-type or chewable form) could not be taken into
account, and therefore, the whole food category (FC 17) was considered in the speciﬁc exposure
scenario including food supplements.
According to information from the Mintel’s GNPD database, E 470a and E 470b are not used in soft
drinks. Thus, considering this and the fact that E 470a and E 470b are used as emulsiﬁers, only milk-
based beverages and other cloudy drinks were considered under FC 14.1.4 Flavoured drinks. E 470a
and E 470b are also allowed in FCs 13.2, 13.3 and 13.4. Food items belonging to these food
categories, consumed by the population groups children, adolescents, adults and the elderly, may be
very diverse and, in addition, there is very limited information on their consumption. Therefore, eating
occasions belonging to these food categories were reclassiﬁed under the food categories in accordance
to their main ingredient. The reported use levels of E 470a and E 470b for FCs 13.2 and 13.3
(Appendix A) were not considered in the exposure assessment.
Both food additives are also authorised for use in FC 18 (Processed foods not covered by categories 1–
17, excluding foods for infants and young children). This food category is very unspeciﬁc and the foods
belonging to this food category in the EFSA Comprehensive Database (e.g. processed foods, prepared or
composite dishes) were therefore also reclassiﬁed under food categories in accordance to their main
ingredient. No use levels of the food additives in this food category were provided to EFSA (Appendix A).
Population Age range
Countries with food consumption surveys covering more
than 1 day
Adolescents From 10 years up to and
including 17 years of age
Austria, Belgium, Cyprus, Czech Republic, Denmark, Finland,
France, Germany, Italy, Latvia, Netherlands, Spain, Sweden, UK
Adults From 18 years up to and
including 64 years of age
Austria, Belgium, Czech Republic, Denmark, Finland, France,
Germany, Hungary, Ireland, Italy, Latvia, Netherlands, Romania,
Spain, Sweden, UK
The elderly(b) From 65 years of age and
older
Austria, Belgium, Denmark, Finland, France, Germany, Hungary,
Ireland, Italy, Netherlands, Romania, Sweden, UK
(a): The term ‘toddlers’ comes from the EFSA Comprehensive Database and corresponds to ‘young children’ in Regulations (EC)
No 1333/2008 and (EU) No 609/2013.
(b): The terms ‘children’ and ‘the elderly’ correspond, respectively, to ‘other children’ and the merge of ‘elderly’ and ‘very elderly’
in the Guidance of EFSA on the ‘Use of the EFSA Comprehensive European Food Consumption Database in Exposure
Assessment’ (EFSA, 2011a).
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For the other food categories, the reﬁnements considering the restrictions/exceptions as set in
Annex II to Regulation No 1333/2008 were applied.
Overall, in the maximum level exposure scenario, 18 food categories were included, while in the
reﬁned (brand loyal and non-brand loyal) scenarios, 12 food categories were included in the exposure
assessment of E 470a,b (Appendix C). Compared to the reﬁned scenario, three additional food
categories were considered (FC 17.1, 17.2 and 17.3) in the food supplement consumers only scenario.
3.4. Exposure estimate
3.4.1. Exposure to sodium, potassium, calcium and magnesium salts of fatty
acids (E 470a, E 470b) from their use as food additives
The Panel carried out a chronic dietary exposure to E 470a and E 470b for the following population
groups: infants, toddlers, children, adolescents, adults and the elderly. Based on information from the
Mintel’s GNPD, the Panel considered that E 470a and E 470b are not likely to be used in combination
in the same food product and, therefore, the exposure assessment of E 470a,b was performed
considering the reported use level for either E 470a or E 470b independently per food category
(Appendix C).
Dietary exposure to E 470a,b was calculated by multiplying concentrations of E 470a,b per food
category (Appendix C) with their respective consumption amount per kilogram body weight for each
individual in the Comprehensive Database. The exposure per food category was subsequently added to
derive an individual total exposure per day. These exposure estimates were averaged over the number
of survey days, resulting in an individual average exposure per day for the survey period. Dietary
surveys with only one day per subject were excluded as they were considered as not adequate to
assess repeated exposure.
This was carried out for all individuals per survey and per population group, resulting in
distributions of individual exposure per survey and population group (Table 5). On the basis of these
distributions, the mean and 95th percentile of exposure were calculated per survey and per population
group. The 95th percentile of exposure was only calculated for those population groups with a
sufﬁciently large sample size (EFSA, 2011a). Accordingly, in this assessment, the 95th percentile of
exposure for infants from Italy and for toddlers from Belgium, Italy and Spain were not estimated.
Exposure assessment of sodium, potassium, calcium and magnesium salts of fatty acids (E 470a,b)
was carried out by the ANS Panel based on: (1) maximum reported use levels (deﬁned as the
maximum level exposure assessment scenario) and (2) maximum and typical reported use levels
(deﬁned as the reﬁned exposure assessment scenario). These two scenarios are discussed in detail
below. These scenarios did not consider the exposure to E 470a,b via the intake of food supplements.
This exposure source is covered in an additional scenario detailed below (food supplements consumers
only scenario).
A possible additional exposure from the use of E 470a or E 470b in food additives, food enzymes,
food ﬂavourings and in nutrients in accordance with Annex III to Regulation (EC) No 1333/2008 (Parts
1, 2, 3, 4 and 5A) was not considered in any of the exposure scenarios due to the absence of
concentration data.
Maximum level exposure assessment scenario
The regulatory maximum level exposure assessment scenario is typically based on the MPLs as set
in Annex II to Regulation (EC) No 1333/2008 and listed in Table 4. As E 470a and E 470b are
authorised at QS in all food categories, a maximum level exposure estimate was calculated based on
the maximum reported use levels provided by industry (food industry and food additive
manufacturers), excluding exposure via food supplements, as described in the EFSA Conceptual
framework (EFSA ANS Panel, 2014). This exposure scenario can therefore consider only food
categories for which the above data were made available to the Panel. Appendix C summarises the
concentration levels of sodium, potassium, calcium and magnesium salts of fatty acids (E 470a,
E 470b) used in this scenario.
The Panel considered that the exposure estimates derived following this scenario was the most
conservative, based on the available data, since it is assumed that that the population will be exposed
to E 470a or E 470b present in food at the maximum reported use levels over a longer period of time.
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Reﬁned exposure assessment scenario
The present reﬁned exposure assessment scenario is based on use levels reported by food industry.
This exposure scenario can consider only food categories for which the above data were made
available to the Panel.
Appendix C summarises the concentration levels of E 470a,b used in the reﬁned exposure
assessment scenario. Based on the available data set, the Panel calculated two reﬁned exposure
estimates based on different model populations:
• The brand-loyal consumer scenario: it was assumed that a consumer is exposed long-term to
E 470a,b present at the maximum reported use for one food category. This exposure estimate
was calculated as follows:
– Combining food consumption with the maximum of the reported use levels for the main
contributing food category at the individual level.
– Using the mean of the typical reported use levels for the remaining food categories.
• The non-brand-loyal consumer scenario: it was assumed that a consumer is exposed long-term
to levels of E 470a,b present at the mean reported use levels in food. This exposure estimate
was calculated using the mean of the typical reported use levels for all food categories.
Food supplement consumers only scenario
Sodium, potassium, calcium and magnesium salts of fatty acids (E 470a, E 470b) are authorised in
FC 17 (Food supplements as deﬁned in Directive 2002/46/EC excluding food supplements for infants
and young children). As exposure via food supplements may deviate largely from that via food, and
the number of food supplement consumers may be low depending on populations and surveys, an
additional scenario was calculated in order to reﬂect additional exposure to food additives from the
intake of food supplements. This scenario was estimated assuming that consumers of food
supplements were exposed to E 470a,b present at the maximum reported usage levels in food
supplements on a daily basis. For the remaining food categories, the mean of the typical reported use
levels was used.
As FC 17 does not consider food supplements for infants and toddlers as deﬁned in the legislation,
the exposure to E 470a,b from food supplements was not estimated for these two population groups.
Appendix C summarises the concentration levels of E 470a,b used in this scenario.
Dietary exposure to sodium, potassium, calcium and magnesium salts of fatty acids
(E 470a, E 470b)
Table 6 summarises the estimated exposure to levels of E 470a,b from their use as food additives
in six population groups (Table 5) according to the different exposure scenarios. Detailed results per
population group and survey are presented in Appendices D and E.
Table 6: Summary of the estimated dietary exposure to sodium, potassium, calcium and
magnesium salts of fatty acids (E 470a,b) from their use as food additives in the
maximum level exposure assessment scenario and in the reﬁned exposure scenarios, in six
population groups (minimum–maximum across the dietary surveys in mg/kg bw per day)
Infants
(12 weeks–
11 months)
Toddlers
(12–35 months)
Children
(3–9 years)
Adolescents
(10–17 years)
Adults
(18–64 years)
The elderly
(≥ 65 years)
Min Max Min Max Min Max Min Max Min Max Min Max
Maximum level exposure assessment scenario
Mean 3 23 6 97 16 72 8 41 11 27 13 22
95th
percentile
22 61 18 160 38 146 20 80 24 64 29 43
Reﬁned estimated exposure assessment scenario
Brand-loyal scenario
Mean 1 22 3 69 7 53 4 27 9 18 8 17
95th
percentile
8 58 9 116 20 127 13 63 20 36 17 33
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In the maximum level exposure assessment scenario, the mean exposure to E 470a,b from their
use as food additives ranged from 3 mg/kg bw per day in infants to 97 mg/kg bw per day in toddlers.
The 95th percentile of exposure ranged from 18 to 160 mg/kg bw per day in toddlers.
In the brand-loyal scenario, mean exposure to E 470a,b ranged from 1 mg/kg bw per day in infants
to 69 mg/kg bw per day in toddlers. The 95th percentile ranged from 8 mg/kg bw per day in infants
to 127 mg/kg bw per day in children. The corresponding exposure levels in the non-brand-loyal
scenario were 1 mg/kg bw per day in infants and 68 mg/kg bw per day in toddlers at the mean level,
and 8 mg/kg bw per day in infants and adolescents to 127 mg/kg bw per day in children at the 95th
percentile of exposure, respectively.
The exposure estimates for the two reﬁned exposure scenarios were similar because FC 07.1 bread
and rolls contributed by far the most to the exposure in all population groups in both scenarios. For
this food category, the reported maximum and typical use levels were the same.
In the food supplements consumers only exposure scenario, mean exposure to E 470a,b ranged for
children between 8 and 58 mg/kg bw per day and between 13 and 17 mg/kg bw per day for adults.
The corresponding 95th percentiles of exposure were 19 and 83 mg/kg bw per day and 30 and
39 mg/kg bw per day for the same two population groups (Appendix E).
In the maximum level exposure assessment scenario, FC 07.1 bread and rolls contributed most to
the total mean exposure in all population groups. In children, adolescents, adults and elderly, another
important contributor was FC 12.6 sauces. This food category was not included in the reﬁned
scenarios, because the reported use levels were from a food additive producer.
In the brand-loyal scenario, the main contributing food category was by far FC 07.1 bread and rolls.
FC 05.2.1 other confectionery with added sugar was also an important contributor for children and
adolescents. FC 05.2.1 had the highest maximum reported use level, except for the food supplements.
In the non-brand-loyal scenario, apart from FC 07.1 bread and rolls, FC 14.1.4 ﬂavoured drinks and
FC 05.2.1 other confectionery with added sugar contributed also largely to the exposure, especially for
children and adolescents.
An overview of the main food categories contributing to the exposure to E 470a,b in the different
exposure scenarios is presented in Appendix F.
Uncertainty analysis
Uncertainties in the exposure assessment of sodium, potassium, calcium and magnesium salts of
fatty acids (E 470a,b) have been discussed above. In accordance with the guidance provided in the
EFSA opinion related to uncertainties in dietary exposure assessment (EFSA, 2007), the following
sources of uncertainties have been considered and summarised in Table 7.
Infants
(12 weeks–
11 months)
Toddlers
(12–35 months)
Children
(3–9 years)
Adolescents
(10–17 years)
Adults
(18–64 years)
The elderly
(≥ 65 years)
Min Max Min Max Min Max Min Max Min Max Min Max
Non-brand-loyal scenario
Mean 1 22 3 68 5 53 3 27 10 18 8 17
95th
percentile
8 58 9 116 13 127 8 63 19 36 17 33
bw: body weight.
Table 7: Qualitative evaluation of inﬂuence of uncertainties on the dietary exposure estimate
Sources of uncertainties Direction(a)
Consumption data:
Different methodologies/representativeness/underreporting/misreporting/no portion size
standard
+/
Use of data from food consumption surveys covering only a few days to estimate high
percentiles (95th) long-term (chronic) exposure
+
Correspondence of reported use levels to the food items in the EFSA Comprehensive Database:
uncertainties to which types of food the levels refer
+/
Uncertainty in possible national differences in use levels within food categories +/
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Sodium, potassium, calcium and magnesium salts of fatty acids (E 470a and E 470b) are authorised
as Group I food additive in 67 food categories and have a speciﬁc authorised use in two food
categories (of which one has only an authorisation for E 470a) (Table 4). Since, the majority of food
categories correspond to the general Group I food additives authorisation (Table 4), E 470a or E 470b
may not necessarily be used in these food categories. This may explain why use levels of E 470a and
E470b were only reported in 24 food categories. However, the Panel noted that information from the
Mintel’s GNPD (Appendix B) showed that a limited number of foods belonging to some of the
remaining 45 food categories were labelled with either E 470a or E 470b, such as unripened cheese,
processed potato products, and processed ﬁsh and ﬁshery products including molluscs and
crustaceans. This may indicate a possible minor underestimation of exposure. In the reﬁned exposure
scenarios and the food supplements consumers only scenario, 12 and 15 food categories were
considered in the exposure assessment, respectively.
The 12 food categories which were taken into account in the reﬁned exposure assessment
scenarios out of all authorised food categories (N = 69), corresponded to only 6–37% of the amount
(grams of foods by body weight) of foods consumed documented in the EFSA Consumption Database.
FC 07.1 bread and rolls was by far the major contributor to the exposure in the reﬁned exposure
scenarios. The Panel however noted that the use levels for this food category had been provided by
only one food industry with an identical maximum and typical level. Furthermore, according to the
Mintel’s GNPD, only 0.1% of the foods belonging to comparable food subcategories as used in Mintel
were reported to contain E 470a (Appendix B).
Certain FCs (FCs 03 Edible ices, 11.2 Other sugars and syrups, FCs 12.2.1 Herbs and Spices, 12.2.2
Seasonings and condiments, 12.6 Sauces and 12.8 Yeast and yeast products) were only considered in
the maximum exposure assessment scenario. For FCs 03, 12.6 and 12.8 with only a (very) limited use
of E 470a or E 470b according to the Mintel’s GNPD, this may not have resulted in an underestimation
of the exposure in the reﬁned scenarios. However, E 470a and E 470b were used to a larger extent in
FC 11.2 (Other sugars and syrups). Ignoring this food category may have resulted in an
underestimation of the exposure in the reﬁned scenarios.
The top-10 Mintel’s GNPD food subcategories in terms of percentage of products containing E 470a
or E 470b in a given subcategory (i.e. Standard & Power Mints, Vitamins & Dietary Supplements,
Mixed Assortments, Other Sugar Confectionery, Medicated Confectionery, Other Natural Sweeteners,
Lollipops, Boiled Sweets, Gum, Liquorice) were included in the food categories considered in the
Sources of uncertainties Direction(a)
Concentration data:
• Levels considered applicable to all foods within the entire food category
• Levels not fully representative of foods on the EU market
+
+/
Food categories included in the exposure assessment: no data for certain food categories which
were therefore not considered in the exposure estimates (n = 45 for max scenario/51 for the
reﬁned scenarios out of 69 authorised food categories)

Food categories selected for the exposure assessment: exclusion of food categories due to
missing FoodEx linkage (n = 1/69 food categories)

Food categories selected for the exposure assessment: inclusion of food categories without
considering the restriction/exception (n = 3 max scenario/n = 2 reﬁned scenarios out of 69
authorised food categories)
+
Foods which may contain the food additives according to Annex III to Regulation (EC) No
1333/2008 not taken into account

Maximum level exposure assessment scenario:
• exposure calculations based on the maximum reported use levels (reported use from
food industry and food additive producers
+
Reﬁned exposure assessment scenarios:
• exposure calculations based on the maximum or mean levels (reported use from food
industries)
+/–
(a): +, uncertainty with potential to cause overestimation of exposure; –, uncertainty with potential to cause underestimation of
exposure.
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reﬁned exposure scenarios (Appendix C) except for ‘Other Natural Sweeteners’, for which no use levels
were available.
Overall, based on the assumption that the food additives are not used in the food categories in
which they are permitted but for which no usage data were provided by industry, the Panel considered
that the uncertainties identiﬁed would, in general, result in an overestimation of the exposure to
E 470a,b as food additives in all exposure scenarios.
3.4.2. Exposure via the regular diet
The Panel considered that because salts of fatty acids are not expected to occur in normal diet, the
exposure of the fatty acid moiety of the food additive was relevant for comparison with the intake of
fatty acids coming from the diet. As, based on the information coming from the industry, salts of fatty
acids (E 470a and E 470b) contain mainly saturated fatty acids, the saturated fatty acid intake from
the diet has been considered.
In 2010, the EFSA NDA Panel issued an opinion on the dietary reference values (DRVs) for fats,
including saturated fatty acids (EFSA NDA Panel, 2010) among European populations for several age
classes and gender. As already done in the ANS opinion on the re-evaluation of fatty acids (E 570)
(EFSA ANS Panel, 2017), the Panel calculated the mean dietary intake of saturated fatty acids taking
into account DRVs for fats in energy percentage in different age classes among European populations.
Accordingly, the minimum–maximum mean intakes of saturated fatty acids derived from all fats in
mg/kg bw per day were approximately 2,500–3,000 mg/kg bw per day in infants, 1,100–1,300 mg/kg
bw per day in toddlers, 900–1,300 mg/kg bw per day in children, 400–700 mg/kg bw per day in
adolescents, 400–1,000 mg/kg bw per day in adults and 300–1,300 mg/kg bw per day in the elderly.
In order to compare the exposure to the salts of fatty acids (as food additives) to the dietary intakes
of saturated fatty acids, a conversion factor was calculated taking into account the EU speciﬁcations on
the ranges of the metals expressed as metal oxides. After consideration of the molecular weights and
the percentage of the metal in the oxides, the average metal content in the food additive was
calculated to be about 8.7%, meaning that 91.3% of the food additive consisted of the fatty acid
moiety. The conversion factor of 0.91 was applied to the mean exposures to E 470a,b to allow
comparison with the intake of saturated fatty acids from the diet. Based on the estimated intakes of
saturated fatty acids via the regular diet and those via the salts of fatty acids (E 470a and E 470b) as
a food additives (Section 3.4.1, non-brand-loyal scenario), the Panel estimated that at the mean the
intake of E 470a and E 470b as food additives may contribute up to 5% to the overall dietary
exposure to saturated fatty acids, calculated as described above.
3.5. Biological and toxicological data
The Panel considered that sodium, potassium, calcium and magnesium salts of fatty acids are
expected to dissociate in the gastrointestinal tract into fatty acid carboxylates and their corresponding
cations as far as the salts are dissolved. The resulting low amounts of sodium, potassium, calcium and
magnesium ions will enter normal physiological processes. Therefore, the properties of the
corresponding cations are not discussed further in the opinion.
3.5.1. Absorption, distribution, metabolism and excretion
No data were available.
3.5.2. Acute oral toxicity
No data were available.
3.5.3. Short-term and subchronic toxicity
No data were available.
3.5.4. Genotoxicity
Belisario et al. (1985) assessed the mutagenicity of calcium caprylate in a Salmonella Typhimurium
bacterial reverse mutation assay (strains TA98, TA100, TA1535, TA1537 and TA1538), with and without
metabolic activation. No mutagenic activity was reported (no further information given).
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Zeiger and Margolin (2000) tested potassium oleate (no details about purity given) in the
bacterial reverse mutation assay using S. Typhimurium strains TA97, TA98, TA100 and TA1535. The
authors reported that the test substance did not induce mutagenic effects in the presence and
absence of metabolic activation (S9). No details were given about doses and cytotoxicity.
Magnesium stearate was tested for mutagenicity in S. Typhimurium strains TA1535, TA1537 and
TA1538 and Saccharomyces cerevisiae strain D4 (Litton Bionetics, 1976 (Documentation provided to
EFSA n. 9)). The highest concentration of the test substance was determined based on the
concentration resulting in 50% survival. Two further concentrations tested were one-half and one-
quarter of this concentration. Accordingly, the substance was tested in the assays at concentrations of
0, 1.25, 2.5 and 5% (w/v), which based on the description of the method, might be equivalent to 0, 25,
50 and 100 mg/plate. The assay was performed in the absence and presence of three metabolic
activation systems (S9-mix) which were prepared with liver of mice, rats and monkeys, respectively. It
was not reported if the S9-mixes were isolated from animals pretreated with inducers. The assays were
performed as plate and pre-incubation (suspension) assays. The results of all assays were reported to
be negative, however, the tables were not clearly presented and therefore difﬁcult to be interpreted.
The study was performed before the OECD guideline No 471 was established. It has some limitations,
e.g. concerning the strains used, the concentrations tested and the reporting of methods and results.
Overall, the Panel noted that the data on the genotoxicity of the salts of fatty acids were limited to
three studies. The mutagenicity of calcium caprylate, potassium oleate and magnesium stearate was
tested in the bacterial reverse mutation assay and negative results were obtained.
3.5.5. Chronic toxicity and carcinogenicity
Sodium oleate (commercial product consisting of 80% sodium oleate; the other constituents
being 5% sodium linoleate, 8% stearate, 5% linolenate, 2% palmitate with arachidonate) was
administered, via the drinking water, for 108 weeks to groups of 50 male and 50 female F344 rats at
levels of 0%, 2.5% and 5.0% (equivalent to 0, 1,250 and 2,500 mg/bw per day and 0, 1,000 and
2,000 mg/kg bw per day for sodium oleate, for males and females, respectively) (Hiasa et al. 1985).
Histopathology was restricted to neoplastic changes and no data on non-neoplastic changes were
reported. Data on clinical signs were not reported. Sodium oleate slightly depressed water
consumption (not signiﬁcantly) in the females, but not in the males. No statistically signiﬁcant effects
were found on survival and body weight. There were no statistically signiﬁcant differences between
treated and control rats in urinalysis and haematology. A slight but signiﬁcant depression in serum
bilirubin was the only ﬁnding in clinical chemistry in males. The signiﬁcant decrease in lactic
dehydrogenase activity and the increase in blood urea nitrogen, which were seen in females at the
2.5%, were not apparent at the 5% dose level. Data on relative organ weights were not reported. The
absolute liver weight in the 5% dose in males was signiﬁcantly reduced (means  standard error of
means: 8.8  1.3 vs 10.8  1.6 g in controls); however, the interindividual variability was high. In
females, minor organ weight effects were reported for heart, adrenal, thymus and pancreas at the 5%
level. The incidences of tumours of the pituitary gland (in males), thyroid gland (in females), adrenal
gland (in males), pancreas (in males) and uterus were slightly higher in treated rats than in the
controls, but the differences were not statistically signiﬁcant with the exception of pancreatic tumours
in males (0 in control, 10% in the low dose and 16% for the high dose) in males. However, according
to the authors, this incidence did not differ signiﬁcantly from the reported spontaneous incidence in
the same strain (4.3–13.0% as reported for example by Maekawa et al. (1983)). The authors did not
identify a NOAEL.
The Panel noted that the pancreatic tumours that were reported were adenoma not carcinoma and,
therefore, considered that sodium oleate did not present a carcinogenic potential. In addition, due to
the limitations in the protocol used (only two doses tested), the Panel considered that it was not
possible to identify a NOAEL from this study.
3.5.6. Reproductive and developmental toxicity
No data were available.
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3.5.7. Other studies
Case reports
Okumura et al. (1998), and also Kurai et al. (2006), reported case reports in which sodium oleate
or calcium stearate induced lung reactions. The Panel considered these reports not relevant for the
evaluation of the safety of salts of fatty acids used as food additives.
Effects on the intestinal tract
Endo et al. (2002) studied the local toxic effects of sodium laurate on colon epithelium in male
Wistar rats in an in situ colon loop assay. Anaesthetised rats (no data about number of animals)
received (after washing of colon) 1 mL of sodium laurate into a 10-cm loop of the colon for 90 min.
Toxic effects were assessed by measuring the elution of phospholipids and total protein in the loop
solution. At a concentration of 10 mM sodium laurate, both parameters were signiﬁcantly increased
suggesting local effects at a high concentrations.
Haematological effects
It has been reported that sodium caprylate and sodium stearate may have some effects on
platelet functions (Tangen et al., 1975) and sodium laurate have been used in a model for induction of
coronary microembolization (Zhu et al., 2017). However, these effects occurred only under very
speciﬁc experimental conditions, which were not relevant for the evaluation of the safety of these salts
of fatty acids used as food additives.
3.5.8. Studies with other emulsiﬁers
Sodium, potassium, calcium salts of fatty acids (E 470a) and magnesium salts of fatty acids
(E 470b) are included in the list of EFEMA index of food emulsiﬁers (EFEMA, 2015).
In several recent studies, some other emulsiﬁers have been reported to alter the gut microbiota, to
promote gut inﬂammation, obesity and to impair glycaemic control (Swidsinski et al., 2009a,b; Renz
et al., 2012; Merga et al., 2014; Cani and Everard, 2015; Chassaing et al., 2015, 2017; Romano-Keeler
and Weitkamp, 2015; Lecomte et al., 2016; Nejrup et al., 2017; Shah et al., 2017; Jiang et al., 2018).
The Panel noted that, even though some of these effects are not systematically studied in toxicity
studies performed according to toxicity testing guidelines, they would be investigated on a case-by-
case basis if indicated by the results of the general toxicity testing as recommended in the Guidance
for submission of food additives (EFSA ANS Panel, 2012). The Panel considered that additional studies
would be needed to show the relevance of the effects seen in mice for human health and if salts of
fatty acids can induce such effects.
3.6. Discussion
The Panel considered that it is unclear, whether, according to the deﬁnition in Regulation 231/2012,
the fatty acids or the salts thereof are occurring in food fats and oils. However, according to the
literature, salts of fatty acids are not expected to occur in signiﬁcant amounts in food fats and oils (low
Na, K, Ca or Mg content and acidic conditions due to free fatty acids). Therefore, this evaluation has
been performed assuming that only the fatty acids (either free or bound) and not the salts of fatty
acids occur in food fats and oils.
According to information from industry, the fatty acids used for the production of sodium,
potassium, calcium and magnesium salts of fatty acids (E 470a and E 470b) are obtained either from
edible (i.e. vegetable or animal) fats and oils or from distilled food fatty acids. In the Regulation, no
indication is given as regards the chemical nature of the fatty acids or the level at which an individual
fatty acid may be present in the food additive E 470a and E 470b.
According to information provided by interested parties, salts of fatty acids consist for 95–99% (by
weight) of salts, of which 4–5% account for the cation. In commercial products, the fatty acid fraction
consists at least of 90% stearic- and palmitic acid with a minimum of 40% stearic acid.
The composition and the nature of the fatty acid moieties depend on the source material used for
the production of the food additive. Next to stearic- and palmitic acid following fatty acids may be
present in concentrations varying between 0% and 1.5%: i.e. lauric (C12) acid, myristic (C14) acid,
pentadecanoic (C15) acid, margaric (C17) acid, oleic acid (C18:1) and arachidic (C20) acid.
E 470a and E 470b can be manufactured by using food oils and fats. Beside natural oils and fats,
also hydrogenated fats and or oils can be used for manufacturing of E 470a and E 470b.
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Some edible oils, such as rapeseed, which can be used for the manufacturing of sodium, potassium
and calcium salts of fatty acids (E 470a) and magnesium salts of fatty acids (E 470b) may contain
erucic acid. A TDI of 7 mg/kg bw per day for erucic acid has been established by the EFSA CONTAM
Panel (EFSA CONTAM Panel, 2016), therefore, the Panel considered that a maximum limit for erucic
acid should be included in the speciﬁcations.
According to information provided by industry (APAG, 2016 (Documentation provided to EFSA n.
2)), nickel present in the starting material could be a potential impurity in the ﬁnal product and no
maximum limit for nickel is included in the speciﬁcations for E 470a and E 470b.
The Panel noted that in Commission Regulation (EU) No 231/2012, the term ‘distilled food fatty
acids’ is used. In the view of the Panel this term should be more clearly described. Indeed, without
any further speciﬁcation of this term, fatty acids that are identical to those present in foods, but that
are produced by distillation from non-food sources, could also be used as source material for the
production of the food additives E 470a and E 470b. The Panel considered that the safety of use of
salts of fatty acids produced using fatty acids, obtained via distillation from non-food sources cannot
be assessed. Therefore, the use of these sources should be avoided.
The Panel noted that recent studies with other emulsiﬁers had demonstrated effects on the
microbiota, which might also be relevant to emulsiﬁers in general; however, there were no speciﬁc
studies on E 470a or E 470b and effects on the microbiota itself.
The Panel noted that sodium, potassium, calcium and magnesium salts of fatty acids are expected
to dissociate in the gastrointestinal tract into fatty acid carboxylates and their corresponding cations.
The resulting low amounts of sodium, potassium, calcium and magnesium ions will enter normal
physiological processes. Therefore, the properties of the corresponding cations are not discussed
further in the opinion and the Panel considered that a read-across approach could be applied for the
evaluation of the sodium, potassium, calcium and magnesium salts of fatty acids (E 470a and E 470b)
using the previous assessment of the food additive fatty acids (E 570) (EFSA ANS Panel, 2017).
The Panel evaluated the ADME of the fatty acids, caprylic-, capric-, oleic-, lauric-, palmitic-,
myristic- and stearic acid, and considered that they, like other fatty acids, were readily and extensively
absorbed from the gastrointestinal tract and metabolised via the b-oxidation pathway and the
tricarboxylic acid cycle to carbon dioxide and excreted (EFSA ANS Panel, 2017).
The Panel noted that the number of toxicological studies on the salts of fatty acids was very
limited.
The Panel considered that:
• As regards genotoxicity, only the mutagenicity studies on calcium caprylate, potassium oleate
and magnesium stearate were available and negative results were obtained. In addition, the
Panel noted that available genotoxicity data for caprylic-, capric-, lauric-, myristic-, palmitic-,
stearic- or oleic acid used as a food additive (E 570) do not raise a concern for genotoxicity
(EFSA ANS Panel, 2017).
• As regards carcinogenicity, the Panel noted that in a study in rats, the pancreatic tumours
reported were adenomas not carcinomas, therefore the Panel considered that sodium oleate
did not present a carcinogenic potential. However, it was not possible to identify a NOAEL from
this study.
• No data were available as regards subchronic toxicity, chronic toxicity, reproductive and
developmental toxicity.
However, the EFSA ANS Panel evaluated the safety of the linear free fatty acids caprylic- (C8),
capric- (C10), lauric- (C12), myristic- (C14), palmitic- (C16), stearic- (C18) and oleic acid (C18:1) when
used as a food additive (E 570) and concluded that the use of these acids were of no safety concern
at the reported use and use levels (EFSA ANS Panel, 2017).
For the exposure assessment of sodium, potassium, calcium and magnesium salts of fatty acids
(E 470a,b), reported uses were available for 24 out of 69 food categories in which E 470a and E 470b
are authorised but only 12 food categories were considered in the reﬁned exposure scenarios. The
Panel noted that the information from the Mintel’s GNPD supported the observation that sodium,
potassium, calcium and magnesium salts of fatty acids (E 470a or E 470b) are apparently not used in
all food categories in which the food additives are authorised.
Based on information from the Mintel’s GNPD, the Panel considered that E 470a and E 470b are not
likely to be used in combination in the same food product and, therefore, the exposure assessment of
E 470a,b was performed considering the reported use level for either E 470a or E 470b independently
per food category.
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As salts of fatty acids are not expected to occur in signiﬁcant amounts in foods, the Panel only
considered the dietary intake of saturated fatty acids (not the salts) to assess the contribution of the
food additives to the intake of saturated fatty acids via all dietary sources. The Panel noted that the
dietary exposure to the fatty acid moieties of E 470a and E 470b represented up to 5% to the overall
dietary exposure to saturated fatty acids, calculated as previously described in Section 3.4.2.
4. Conclusions
Considering that:
• sodium, potassium, calcium and magnesium salts of fatty acids are expected to dissociate in
the gastrointestinal tract to fatty acid carboxylates and their corresponding cations,
• according to information from industry, palmitic acid and stearic acid are the main fatty acids
present in E 470a and E 470b,
• palmitic acid and stearic acid are fatty acids included in the food additive E 570 which was
already evaluated by the Panel and for which it was concluded that its use was of no safety
concern,
• the fatty acid moieties of sodium, potassium, calcium and magnesium salts of fatty acids
(E 470a and E 470b) contributed at the mean maximally to 5% of the overall dietary exposure
of saturated fatty acids,
the Panel concluded that there was no need for a numerical ADI and that the food additives
sodium, potassium, calcium and magnesium salts of fatty acids (E 470a and E 470b) were of no safety
concern at the reported uses and use levels.
5. Recommendations
The Panel recommended that:
• the European Commission considers lowering the current limits for toxic elements (arsenic,
lead, mercury and cadmium) in the EU speciﬁcations for sodium, potassium and calcium salts
of fatty acids (E 470a) and magnesium salts of fatty acids (E 470b) in order to ensure that the
food additive will not be a signiﬁcant source of exposure to these toxic elements in food.
• the European Commission considers revising the EU speciﬁcations for sodium, potassium and
calcium salts of fatty acids (E 470a) and magnesium salts of fatty acids (E 470b) including
maximum limits for nickel.
• the European Commission considers revising the EU speciﬁcations for sodium, potassium and
calcium salts of fatty acids (E 470a) and magnesium salts of fatty acids (E 470b) including
maximum limits for trans-fatty acids because sodium, potassium and calcium salts of fatty acids
(E 470a) and magnesium salts of fatty acids (E 470b) can be manufactured by glycerolysis of
hydrogenated fats and/or oils, which contain signiﬁcant amounts of trans fatty acids.
• the European Commission considers revising the EU speciﬁcations for sodium, potassium and
calcium salts of fatty acids (E 470a) and magnesium salts of fatty acids (E 470b) including
maximum limits for erucic acid because as erucic acid can be present among the fatty acids in
edible oils, which can be used for manufacturing of sodium, potassium and calcium salts of
fatty acids (E 470a) and magnesium salts of fatty acids (E 470b).
• the European Commission considers revising the EU speciﬁcations for sodium, potassium and
calcium salts of fatty acids (E 470a) and magnesium salts of fatty acids (E 470b) by rephrasing
the deﬁnition in order to clarify that the fatty acids used as source materials be obtained only
from edible fats and oils.
• in the event that practices reported in this opinion change (e.g. sources of starting material,
uses and use levels) revision of this evaluation would be needed.
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Abbreviations
ADI acceptable daily intake
ADME absorption, distribution,. metabolism, excretion
AESGP Association of the European Self-Medication Industry
ANS EFSA Scientiﬁc Panel on Food Additives and Nutrient Sources added to Food
AV acid value
bw body weight
CAS Chemical Abstracts Service
CONTAM EFSA Panel on Contaminants in Food Chain
DMSO dimethyl sulfoxide
DRV dietary reference value
EHPM European federation of Associations of Health Products Manufacturers
EINECS European Inventory of Existing Chemical Substances
FAO Food and Agriculture Organization of the United Nations
FCs food categories
FCS food categorisation system
FDE Food Drink Europe
FSE Food Supplements Europe
GC gas chromatography
GLC gas liquid chromatography
GNPD Global New Products Database
IARC International Agency for Research on Cancer
ICGA International Chewing Gum Association
IFAC International Food Additives Council
JECFA Joint FAO/WHO Expert Committee on Food Additives
LOGES Dr. Loges - Naturheilkunde neu entdecken
MPL maximum permitted level
NDA EFSA Panel on Dietetic Products, Nutrition and Allergies
NOAEL no observed adverse effect level
OECD Organisation for Economic Co-operation and Development
QS quantum satis
TDI tolerable daily intake
SCF Scientiﬁc Committee on Food
TemaNord is a publishing series for results of the often research-based work that working groups
or projects under Nordic Council of Ministers have put in motion
WHO World Health Organization
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Appendix A – Summary of reported use levels of E 470a and E 470b
provided by industry (mg/kg)
Appendix B – Number and Percentage of food products labelled with
E 470a and E 470b as present on the Mintel GNPD per food sub-category
between 2012 and 2017
Appendix C – Concentration levels of E 470a,b used in the MPL and in the
reﬁned exposure scenarios (mg/kg or mL/kg as appropriate)
Appendix D – Summary of total estimated exposure of E 470a,b from their
use as food additives for the maximum level exposure scenario and the
reﬁned exposure assessment scenarios per population group and survey:
mean and 95th percentile (mg/kg bw per day)
Appendix E – Summary of total estimated exposure of E 470a,b from their
use as food additives for the food supplement consumer only scenario per
population group and survey: mean and 95th percentile (mg/kg bw per
day)
Appendix F – Main food categories contributing to exposure to E 470a,b
using the maximum level exposure scenario and the reﬁned exposure
assessment scenarios (> 5% to the total mean exposure)
Appendices A–F can be found in the online version of this output (‘Supporting information’ section):
http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2018.5180/suppinfo/
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